Grant: Discovery Launch Supplement
University of Manitoba
$12,500.00
Exploring the gene expression programs and cell fate decisions that underlie human blood development
FY 2024-25
Summary
The human hematopoietic system is composed of red blood cells, which carry oxygen throughout the body, and lymphoid and myeloid cells which protect us from foreign pathogens. All of these blood cell types differentiate from a common pool of hematopoietic stem and progenitor cells in a process called haematopoiesis. Haematopoiesis is fundamental to human development and homeostasis, but the molecular programs that govern this process are not fully understood. A significant barrier for understanding blood development is the ethical and practical inaccessibility of primary human tissue samples. Even when these samples can be accessed, they cannot easily be genetically perturbed. Therefore, the causal roles that genes play in blood cell fate determination are largely unconfirmed.
My lab creates and uses in vitro differentiation technology to direct human stem cells to develop into mature blood cells in the dish. We are experts in using single cell genomics and computational models to predict which genes are responsible for cellular differentiation. We also have the ability to genetically manipulate cells that are undergoing in vitro differentiation.
The long-term objective of this program is to use in vitro differentiation, single cell genomics, computational modelling and genetic perturbations to provide a detailed and comprehensive understanding of the molecular programs that tell a blood stem cell what mature blood cell type it should become.
Our short-term objectives are to: 1. Determine which genes are required to retain multipotency and maintain proliferation during human blood development. 2. Determine which transcription factors control the bifurcation between mast and myeloid cell fates.
These objectives address important, fundamental and timely questions about blood development that build on my previous work and expertise. To answer these questions, my HQP and I will use an integrated pipeline comprising gene editing, multiomic analysis of gene expression profiles and epigenetic state in single cells, and bioinformatics. Beyond addressing our short-term objectives, this innovative pipeline can be applied to study a broad range of developmental programs enabling natural sciences researchers in their efforts to understand how stem cells create tissues.
This research program will provide enhanced training opportunities for three graduate students, three undergraduates and one technician to learn techniques in gene editing, single-cell genomics, computational analysis, stem cell culture and developmental immunology as well as project management and scientific communication skills. These technical and leadership skills are in high demand in Canada for impactful roles in natural sciences and engineering across academia, industry, non-profit, government and beyond.
Program
Discovery Launch Supplement
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
DGECR-2024-00255
Name nom
Michaels, Yale
Department département
Biochemistry and Medical Genetics
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
12500
Program id
DGECR
Program name en
Discovery Launch Supplement
Program name fr
Supplément Tremplin vers la découverte
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5302
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Gene expression
Research subject fr
Expression génétique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Exploring the gene expression programs and cell fate decisions that underlie human blood development
Keywords
hematopoiesis; single cell genomics; gene regulatory networks; molecular biology; developmental immunology
Application summary
The human hematopoietic system is composed of red blood cells, which carry oxygen throughout the body, and lymphoid and myeloid cells which protect us from foreign pathogens. All of these blood cell types differentiate from a common pool of hematopoietic stem and progenitor cells in a process called haematopoiesis. Haematopoiesis is fundamental to human development and homeostasis, but the molecular programs that govern this process are not fully understood. A significant barrier for understanding blood development is the ethical and practical inaccessibility of primary human tissue samples. Even when these samples can be accessed, they cannot easily be genetically perturbed. Therefore, the causal roles that genes play in blood cell fate determination are largely unconfirmed.
My lab creates and uses in vitro differentiation technology to direct human stem cells to develop into mature blood cells in the dish. We are experts in using single cell genomics and computational models to predict which genes are responsible for cellular differentiation. We also have the ability to genetically manipulate cells that are undergoing in vitro differentiation.
The long-term objective of this program is to use in vitro differentiation, single cell genomics, computational modelling and genetic perturbations to provide a detailed and comprehensive understanding of the molecular programs that tell a blood stem cell what mature blood cell type it should become.
Our short-term objectives are to: 1. Determine which genes are required to retain multipotency and maintain proliferation during human blood development. 2. Determine which transcription factors control the bifurcation between mast and myeloid cell fates.
These objectives address important, fundamental and timely questions about blood development that build on my previous work and expertise. To answer these questions, my HQP and I will use an integrated pipeline comprising gene editing, multiomic analysis of gene expression profiles and epigenetic state in single cells, and bioinformatics. Beyond addressing our short-term objectives, this innovative pipeline can be applied to study a broad range of developmental programs enabling natural sciences researchers in their efforts to understand how stem cells create tissues.
This research program will provide enhanced training opportunities for three graduate students, three undergraduates and one technician to learn techniques in gene editing, single-cell genomics, computational analysis, stem cell culture and developmental immunology as well as project management and scientific communication skills. These technical and leadership skills are in high demand in Canada for impactful roles in natural sciences and engineering across academia, industry, non-profit, government and beyond.